AgeX Therapeutics: A Massive Upward Spike ?

age-stock-ibr-call-AgeX-Therapeutics-(NYSE: $AGE)-internet-bull-report

Shares of AgeX Therapeutics (NYSE: $AGE) closed at $2.48 Thursday evening, up 195% from the previous day following news of a significant stake from Juvenescence – Hitting IBR’s target.

The Company’s shares jumped as much as 450% on Thursday October 8 – four months after IBR’s analysis and strong buy recommendation.

The target share price of $2.50 has been hit. 

stock-price-ibr-call-AgeX-Therapeutics-(NYSE: $AGE)-internet-bull-report

That is a solid 166% return – or 322% if you managed to sell at the top.

A few months ago, in a comprehensive report on AgeX Therapeutics, IBR recommended a strong buy due to the company’s huge potential and stellar management. 

Juvenescence announced it had obtained a 50% stake in AgeX Therapeutics. 

Our favorite saying applies: ‘The pigs get fed and the hogs get slaughtered” – Don’t be afraid to take some profits off the table.


Parsa Nikoy

Parsa is entering his third year at Henley Business School at the University of Reading, pursuing a bachelor's degree in Accounting and Finance. During his undergraduate studies, he has been an eager member of the finance society, participating in a day-long trading simulation where he attained first place as a market maker and sales trader. Parsa manages a personal portfolio of common stocks. With a long-term horizon, he looks for undervalued small-cap businesses that will yield considerable returns in 10 to 20 years. In his free time, Parsa enjoys reading, listening to podcasts, and continually expanding his knowledge of investing. He is also an avid boxer and trains frequently.